UTHR logo

UTHR Free Cash Flow

Annual FCF:

$1.08B+$333.00M(+44.54%)
December 31, 2024

Summary

  • As of today, UTHR annual free cash flow is $1.08 billion, with the most recent change of +$333.00 million (+44.54%) on December 31, 2024.
  • During the last 3 years, UTHR annual free cash flow has risen by +$603.20 million (+126.35%).
  • UTHR annual free cash flow is now at all-time high.

Performance

UTHR Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

Quarterly FCF:

$346.10M+$216.60M(+167.26%)
September 30, 2025

Summary

  • As of today, UTHR quarterly free cash flow is $346.10 million, with the most recent change of +$216.60 million (+167.26%) on September 30, 2025.
  • Over the past year, UTHR quarterly free cash flow has increased by +$48.10 million (+16.14%).
  • UTHR quarterly free cash flow is now -10.41% below its all-time high of $386.30 million, reached on March 31, 2025.

Performance

UTHR Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

TTM FCF:

$1.12B+$48.10M(+4.50%)
September 30, 2025

Summary

  • As of today, UTHR TTM free cash flow is $1.12 billion, with the most recent change of +$48.10 million (+4.50%) on September 30, 2025.
  • Over the past year, UTHR TTM free cash flow has increased by +$218.30 million (+24.31%).
  • UTHR TTM free cash flow is now -0.84% below its all-time high of $1.13 billion, reached on March 31, 2025.

Performance

UTHR TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherUTHRcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

UTHR Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+44.5%+16.1%+24.3%
3Y3 Years+126.3%+82.3%+64.4%
5Y5 Years+472.2%+47.2%+69.1%

UTHR Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+126.3%-10.4%+461.9%-0.8%+70.1%
5Y5-Yearat high+472.2%-10.4%+461.9%-0.8%+133.8%
All-TimeAll-Timeat high+472.2%-10.4%+153.0%-0.8%+459.8%

UTHR Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2025
-
$346.10M(+167.3%)
$1.12B(+4.5%)
Jun 2025
-
$129.50M(-66.5%)
$1.07B(-5.1%)
Mar 2025
-
$386.30M(+51.8%)
$1.13B(+4.5%)
Dec 2024
$1.08B(+44.5%)
$254.50M(-14.6%)
$1.08B(+20.0%)
Sep 2024
-
$298.00M(+59.3%)
$898.10M(+2.0%)
Jun 2024
-
$187.10M(-44.7%)
$880.60M(+16.6%)
Mar 2024
-
$338.30M(+352.9%)
$755.10M(+1.0%)
Dec 2023
$747.60M(+12.6%)
$74.70M(-73.4%)
$747.60M(-0.9%)
Sep 2023
-
$280.50M(+355.4%)
$754.10M(+13.7%)
Jun 2023
-
$61.60M(-81.4%)
$663.40M(-6.8%)
Mar 2023
-
$330.80M(+307.4%)
$711.80M(+8.5%)
Dec 2022
$663.70M(+39.0%)
$81.20M(-57.2%)
$656.20M(-3.4%)
Sep 2022
-
$189.80M(+72.5%)
$679.00M(+4.2%)
Jun 2022
-
$110.00M(-60.0%)
$651.50M(-3.3%)
Mar 2022
-
$275.20M(+164.6%)
$673.40M(+41.1%)
Dec 2021
$477.40M(-31.4%)
$104.00M(-35.9%)
$477.40M(-1.7%)
Sep 2021
-
$162.30M(+23.0%)
$485.60M(-13.0%)
Jun 2021
-
$131.90M(+66.5%)
$558.40M(-2.4%)
Mar 2021
-
$79.20M(-29.4%)
$572.30M(-17.6%)
Dec 2020
$696.40M(+339.9%)
$112.20M(-52.3%)
$694.70M(+5.2%)
Sep 2020
-
$235.10M(+61.2%)
$660.30M(+10.6%)
Jun 2020
-
$145.80M(-27.7%)
$597.00M(+5.9%)
Mar 2020
-
$201.60M(+159.1%)
$563.80M(+294.2%)
Dec 2019
-$290.30M(-148.9%)
$77.80M(-54.7%)
-$290.30M(+3.7%)
Sep 2019
-
$171.80M(+52.6%)
-$301.50M(+2.8%)
Jun 2019
-
$112.60M(+117.3%)
-$310.30M(-4.6%)
Mar 2019
-
-$652.50M(-1079.7%)
-$296.60M(-149.9%)
Dec 2018
$594.00M(+53.1%)
$66.60M(-59.1%)
$594.00M(+43.5%)
Sep 2018
-
$163.00M(+29.1%)
$413.80M(-15.1%)
Jun 2018
-
$126.30M(-47.0%)
$487.30M(+18.6%)
Mar 2018
-
$238.10M(+309.6%)
$410.80M(+5.9%)
Dec 2017
$387.90M(-35.9%)
-$113.60M(-148.0%)
$387.90M(-40.3%)
Sep 2017
-
$236.50M(+374.9%)
$650.20M(+2.7%)
Jun 2017
-
$49.80M(-76.9%)
$633.30M(-9.4%)
Mar 2017
-
$215.20M(+44.7%)
$698.80M(+16.4%)
Dec 2016
$605.60M(+81.9%)
$148.70M(-32.3%)
$600.40M(+34.7%)
Sep 2016
-
$219.60M(+90.5%)
$445.68M(+5.4%)
Jun 2016
-
$115.30M(-1.3%)
$422.95M(+22.7%)
Mar 2016
-
$116.80M(+2039.9%)
$344.80M(+3.6%)
Dec 2015
$333.00M(+8.2%)
-$6.02M(-103.1%)
$332.97M(-22.1%)
Sep 2015
-
$196.87M(+430.0%)
$427.31M(+0.5%)
Jun 2015
-
$37.15M(-64.6%)
$425.33M(+32.6%)
Mar 2015
-
$104.97M(+18.8%)
$320.87M(+4.2%)
Dec 2014
$307.90M(-21.7%)
$88.32M(-54.7%)
$307.82M(-0.9%)
Sep 2014
-
$194.89M(+389.5%)
$310.50M(+26.5%)
Jun 2014
-
-$67.32M(-173.2%)
$245.50M(-37.3%)
Mar 2014
-
$91.92M(+1.0%)
$391.82M(-0.4%)
Dec 2013
$393.36M(+85.8%)
$91.01M(-29.9%)
$393.36M(+1.8%)
Sep 2013
-
$129.88M(+64.4%)
$386.30M(+12.6%)
Jun 2013
-
$79.01M(-15.5%)
$343.14M(+11.5%)
Mar 2013
-
$93.45M(+11.3%)
$307.88M(+45.4%)
Dec 2012
$211.72M
$83.95M(-3.2%)
$211.72M(+17.5%)
Sep 2012
-
$86.72M(+98.2%)
$180.15M(+15.3%)
Jun 2012
-
$43.75M(+1722.1%)
$156.26M(-5.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$2.70M(-105.1%)
$164.51M(-23.2%)
Dec 2011
$214.22M(+11.1%)
$52.38M(-16.6%)
$214.22M(+9.5%)
Sep 2011
-
$62.84M(+20.9%)
$195.65M(-15.5%)
Jun 2011
-
$51.99M(+10.6%)
$231.56M(+9.2%)
Mar 2011
-
$47.02M(+39.1%)
$212.05M(+9.9%)
Dec 2010
$192.89M(+4362.0%)
$33.81M(-65.8%)
$192.89M(+19.4%)
Sep 2010
-
$98.75M(+204.0%)
$161.56M(+195.1%)
Jun 2010
-
$32.48M(+16.6%)
$54.74M(+9.4%)
Mar 2010
-
$27.86M(+1025.1%)
$50.05M(+2150.4%)
Dec 2009
$4.32M(+102.5%)
$2.48M(+130.7%)
$2.22M(+101.3%)
Sep 2009
-
-$8.07M(-129.0%)
-$165.23M(+10.8%)
Jun 2009
-
$27.79M(+239.1%)
-$185.27M(+14.0%)
Mar 2009
-
-$19.97M(+87.9%)
-$215.39M(-24.1%)
Dec 2008
-$173.61M(-1787.3%)
-$164.98M(-487.0%)
-$173.59M(-349.4%)
Sep 2008
-
-$28.11M(-1103.8%)
-$38.63M(-509.5%)
Jun 2008
-
-$2.33M(-110.7%)
$9.43M(-65.3%)
Mar 2008
-
$21.84M(+172.7%)
$27.16M(+160.6%)
Dec 2007
$10.29M(-69.5%)
-$30.02M(-250.5%)
$10.43M(-69.1%)
Sep 2007
-
$19.95M(+29.6%)
$33.76M(+19.5%)
Jun 2007
-
$15.39M(+202.0%)
$28.24M(+9.2%)
Mar 2007
-
$5.10M(+176.2%)
$25.87M(-28.4%)
Dec 2006
$33.75M(-8.9%)
-$6.69M(-146.3%)
$36.15M(-26.2%)
Sep 2006
-
$14.44M(+10.9%)
$48.99M(-0.5%)
Jun 2006
-
$13.02M(-15.3%)
$49.23M(+2.0%)
Mar 2006
-
$15.38M(+150.0%)
$48.25M(+28.4%)
Dec 2005
$37.05M(+138.1%)
$6.15M(-58.1%)
$37.58M(+11.2%)
Sep 2005
-
$14.68M(+21.8%)
$33.81M(+20.1%)
Jun 2005
-
$12.05M(+155.8%)
$28.16M(+38.0%)
Mar 2005
-
$4.71M(+98.3%)
$20.40M(+31.1%)
Dec 2004
$15.56M(+200.0%)
$2.38M(-73.7%)
$15.56M(+808.9%)
Sep 2004
-
$9.03M(+110.5%)
-$2.19M(+70.4%)
Jun 2004
-
$4.29M(+3502.4%)
-$7.42M(+47.8%)
Mar 2004
-
-$126.00K(+99.2%)
-$14.20M(+8.8%)
Dec 2003
-$15.57M(+39.8%)
-$15.38M(-504.7%)
-$15.57M(-1727.0%)
Sep 2003
-
$3.80M(+252.3%)
-$852.00K(+93.6%)
Jun 2003
-
-$2.50M(-67.3%)
-$13.36M(+27.2%)
Mar 2003
-
-$1.49M(-123.5%)
-$18.34M(+29.0%)
Dec 2002
-$25.84M(+34.7%)
-$667.00K(+92.3%)
-$25.84M(+21.2%)
Sep 2002
-
-$8.70M(-16.4%)
-$32.80M(+9.3%)
Jun 2002
-
-$7.48M(+16.9%)
-$36.17M(+9.1%)
Mar 2002
-
-$8.99M(-17.9%)
-$39.79M(-0.5%)
Dec 2001
-$39.59M(-24.7%)
-$7.63M(+36.8%)
-$39.59M(+6.3%)
Sep 2001
-
-$12.08M(-8.9%)
-$42.26M(-19.5%)
Jun 2001
-
-$11.09M(-26.2%)
-$35.36M(-6.3%)
Mar 2001
-
-$8.79M(+14.7%)
-$33.28M(-4.8%)
Dec 2000
-$31.75M(-22.1%)
-$10.30M(-98.6%)
-$31.75M(-8.6%)
Sep 2000
-
-$5.19M(+42.4%)
-$29.24M(+6.3%)
Jun 2000
-
-$9.01M(-24.1%)
-$31.19M(-4.7%)
Mar 2000
-
-$7.26M(+6.7%)
-$29.80M(-16.0%)
Dec 1999
-$26.00M(-145.3%)
-$7.78M(-9.0%)
-$25.69M(-43.5%)
Sep 1999
-
-$7.14M(+6.2%)
-$17.91M(-66.3%)
Jun 1999
-
-$7.61M(-141.4%)
-$10.77M(-241.4%)
Mar 1999
-
-$3.15M
-$3.15M
Dec 1998
-$10.60M
-
-

FAQ

  • What is United Therapeutics Corporation annual free cash flow?
  • What is the all-time high annual free cash flow for United Therapeutics Corporation?
  • What is United Therapeutics Corporation annual free cash flow year-on-year change?
  • What is United Therapeutics Corporation quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for United Therapeutics Corporation?
  • What is United Therapeutics Corporation quarterly free cash flow year-on-year change?
  • What is United Therapeutics Corporation TTM free cash flow?
  • What is the all-time high TTM free cash flow for United Therapeutics Corporation?
  • What is United Therapeutics Corporation TTM free cash flow year-on-year change?

What is United Therapeutics Corporation annual free cash flow?

The current annual free cash flow of UTHR is $1.08B

What is the all-time high annual free cash flow for United Therapeutics Corporation?

United Therapeutics Corporation all-time high annual free cash flow is $1.08B

What is United Therapeutics Corporation annual free cash flow year-on-year change?

Over the past year, UTHR annual free cash flow has changed by +$333.00M (+44.54%)

What is United Therapeutics Corporation quarterly free cash flow?

The current quarterly free cash flow of UTHR is $346.10M

What is the all-time high quarterly free cash flow for United Therapeutics Corporation?

United Therapeutics Corporation all-time high quarterly free cash flow is $386.30M

What is United Therapeutics Corporation quarterly free cash flow year-on-year change?

Over the past year, UTHR quarterly free cash flow has changed by +$48.10M (+16.14%)

What is United Therapeutics Corporation TTM free cash flow?

The current TTM free cash flow of UTHR is $1.12B

What is the all-time high TTM free cash flow for United Therapeutics Corporation?

United Therapeutics Corporation all-time high TTM free cash flow is $1.13B

What is United Therapeutics Corporation TTM free cash flow year-on-year change?

Over the past year, UTHR TTM free cash flow has changed by +$218.30M (+24.31%)
On this page